Christian de Duve was a Nobel Prize winning cell biologist whose research centered on the separation and characterization of the organelles of living cells. de Duve and his colleagues also made significant contributions to the development of techniques and instrumentation for the study of cell biology. More »
Researchers at The Rockefeller University and the Howard Hughes Medical Institute have identified the mechanism by which the cell’s protein recycler, the proteasome, ramps up its activity to take care of unwanted and potentially toxic proteins. The finding, which has implications for treating muscle wasting and neurodegeneration, also suggests that small molecule inhibitors of this mechanism may be clinically useful in treating multiple myeloma. More »
April 2, 2013
Obama to Unveil Initiative to Map the Human Brain
President Obama on Tuesday will announce a research initiative, starting with $100 million in 2014, to invent and refine new technologies to understand the human brain. Rockefeller's Cori Bargmann will help lead a study of the brain in action.
Hang, a chemist who works to develop new tools for the study of host-pathogen interactions, has discovered that many proteins involved in host immunity to viruses and bacteria are regulated by fatty acid modifications.
March 6, 2013
Legendary drug industry executives warn U.S. science cuts endanger the future
“In short, even prior to the 5 percent budget cut brought about last week by sequestration, our basic research enterprise has been in crisis. This erosion in our basic science investment has occurred at the very time that the biomedical revolution has opened huge opportunities to advance our knowledge of disease.”
February 21, 2013
How Stress Gets Under the Skin: Q&A With Neuroscientist Bruce McEwen
In a Q&A for Time Magazine, RU’s Bruce McEwen counters the notion that all stress is bad, and says some individuals are genetically inclined to thrive in a stressful environment.
March 7, 2013
Women in science: Women’s work
A recent issue of Nature magazine features a special section dedicated to women in science and the barriers they face at research institutions in the United States and abroad. The issue contains commentary, analysis and interactive features that address the persistent gender gap in science today.
Two Rockefeller University scientists are among 11 winners of the first annual Breakthrough Prize in Life Sciences, an award established by six tech entrepreneurs dedicated to advancing breakthrough research. At $3 million each, the prizes are worth more than twice the amount of the Nobel. They were created to recognize excellence in research aimed at curing intractable diseases and extended human life.
Administered by a new non-profit organization, the Breakthrough Prize in Life Sciences Foundation, the prize is founded by Art Levinson, chairman of the board of Apple and former CEO of Genentech; Sergey Brin, co-founder of Google Inc.; Anne Wojcicki, co-founder of 23andMe; Mark Zuckerberg, founder and CEO of Facebook, and his wife Pricilla Chan; and Yuri Milner, founder of the Russian internet company Mail.ru. More »
Researchers led by Rockefeller’s Jesse Ausubel analyzed factors such as global land use and population growth over the last 50 years. Looking at the production index of all crops of the UN’s Food and Agriculture Organization, they found that from 1961 to 2009 land farmed grew by only 12 percent while the index rose about 300 percent.
The textbook, conceived and edited by Rockefeller University professor Donald W. Pfaff, is a 3,200 page, five-volume overview of both basic science and clinical issues in modern neuroscience, aimed at premedical, medical and graduate students.
Rice, head of the Laboratory of Virology and Infectious Disease at Rockefeller, has been awarded the 100,000 euro prize for his description of the molecular and cellular basis of hepatitis C infection in humans.
Darnell will direct all aspects of the NYGC, including its scientific and research activities, and the recruitment and development of a world-class scientific team in genomic research and medicine. Founded in 2010, the NYGC will be one of the largest genomics research facilities in North America, integrating sequencing, bioinformatics and data management. More »